Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

In a Nature News opinion piece, James Shelton, science adviser for USAID's Bureau for Global Health, discusses media coverage of recent findings from the journal Lancet Infectious Diseases showing that women's use of hormonal contraception (HC) may increase the risk of HIV acquisition or transmission. "Whether HC influences HIV risk is a serious concern, and has been the subject of numerous studies. But these studies have been observational and not randomized, and thus potentially biased by who chooses to use HC," Shelton writes. He uses "causality criteria laid down by British epidemiologist Austin Bradford Hill" to analyze the results, adding, "I find the evidence far from persuasive."

He reviews coverage of the data presented by the study authors, comment authors, the journal and the New York Times, saying that these actors presented "little critical thinking" in their reviews. Shelton concludes that the possible relationship between HC and HIV acquisition and transmission "remains a complicated and serious issue," and "[w]e deserve better [reporting], from all involved" (11/2).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into the mechanisms of efavirenz-induced neurotoxicity